Co-occurrence analysis relates a macrolide resistome to the pulmonary microbiome in chronic respiratory disease

J. Narayana (Singapore, Singapore), M. Mac Aogáin (Singapore, Singapore), K. Lau Jia Xu (Singapore, Singapore), Z. Cai (Singapore, Singapore), R. Purbojati (Singapore, Singapore), D. Drautz-Moses (Singapore, Singapore), N. Gaultier (Singapore, Singapore), T. Jaggi (Singapore, Singapore), P. Tiew (Singapore, Singapore), T. Ong (Singapore, Singapore), M. Koh (Singapore, Singapore), A. Lim (Singapore, Singapore), J. Abisheganaden (Singapore, Singapore), K. Tsaneva-Atanasova (Exeter, United Kingdom), S. Schuster (Singapore, Singapore), S. Chotirmall (Singapore, Singapore)

Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Session: Airway infection: the microbiome and beyond
Session type: Oral Presentation
Number: 4934
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Narayana (Singapore, Singapore), M. Mac Aogáin (Singapore, Singapore), K. Lau Jia Xu (Singapore, Singapore), Z. Cai (Singapore, Singapore), R. Purbojati (Singapore, Singapore), D. Drautz-Moses (Singapore, Singapore), N. Gaultier (Singapore, Singapore), T. Jaggi (Singapore, Singapore), P. Tiew (Singapore, Singapore), T. Ong (Singapore, Singapore), M. Koh (Singapore, Singapore), A. Lim (Singapore, Singapore), J. Abisheganaden (Singapore, Singapore), K. Tsaneva-Atanasova (Exeter, United Kingdom), S. Schuster (Singapore, Singapore), S. Chotirmall (Singapore, Singapore). Co-occurrence analysis relates a macrolide resistome to the pulmonary microbiome in chronic respiratory disease. 4934

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The airway ‘resistome’ in chronic respiratory disease: a metagenomics approach
Source: International Congress 2019 – The microbiome: novel data across respiratory diseases
Year: 2019



The microbiome in chronic respiratory diseases
Source: International Congress 2017 – Can we translate the microbiome from basic science to clinical practice?
Year: 2017


Relationship between the respiratory microbiome and systemic patterns in COPD
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018



Metagenomic analysis of lower airway microbial diversity in patients with chronic pulmonary disease
Source: Annual Congress 2011 - Mechanisms and outcomes of infective exacerbations of COPD
Year: 2011


From culturomics to metagenomics: the mycobiome in chronic respiratory diseases
Source: Eur Respir Monogr 2019; 83: 88-118
Year: 2019


Evolution of antimicrobial susceptibility of respiratory isolates in chronic obstructive pulmonary patients diagnosed of acquired community pneumonia
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015

The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis
Source: Eur Respir Rev, 28 (152) 190045; 10.1183/16000617.0045-2019
Year: 2019



Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease
Source: Eur Respir J , 49 (3) 1601328; DOI: 10.1183/13993003.01328-2016
Year: 2017



History of pulmonary tuberculosis was associated with lung microbiome change in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020

Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens
Source: Eur Respir Rev, 28 (152) 190041; 10.1183/16000617.0041-2019
Year: 2019



The consequences of microbiome and pathogen dynamics for chronic lung diseases
Source: Annual Congress 2012 - The bacterial microbiota: implications for health and disease - joint session with the World Allergy Organisation
Year: 2012


Presentation by an expert: Emerging relationships between airway microbiota and chronic respiratory disease : mechanisms of disease onset
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013

The respiratory microbiome in chronic obstructive pulmonary disease (COPD) exacerbations: Relationships with clinical characteristics
Source: Annual Congress 2012 - Hot topics in respiratory infections
Year: 2012

Oropharyngeal and sputum microbiome dynamics with the same pattern following exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018


Relationship between bacterial flora and pulmonary function in patients with acute exacerbations of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 566s
Year: 2003

Targeting the microbiome in respiratory diseases
Source: International Congress 2018 – Microbiomes in respiratory disease
Year: 2018


Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018




How resistance is changing the etiology of acute and chronic respiratory infections?
Source: International Congress 2015 – Antibiotic resistance in respiratory infections
Year: 2015



Bacteria, antibiotics and COPD
Source: Eur Respir J 2001; 17: 995-1007
Year: 2001